The coronavirus known as COVID-19 first appeared in December, 2019 and spread around the world within a matter of days. As of this writing, it has infected nearly 400,000 people in 169 countries.
Scientists around the world have stopped their normal research to focus on creating a vaccine and treatment for this illness which has killed more than 17,000 people worldwide. Fortunately, more than 100,000 have recovered.
On March 22, 2020, an international team of scientists published a research paper preprint on biorXiv analyzing the interaction between the novel coronavirus and human proteins.* Their analysis predicts 332 protein-protein interactions and 69 existing pharmaceuticals that might perturb these interactions. The researchers propose that these drugs may be candidates for treating COVID-19 infections.
LKT Laboratories has a number of these proposed chemicals for COVID-19 research in stock that can be shipped within 24 hours:
We also have various other antiviral compounds available:
*A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing, David E. Gordon et al., bioRxiv 2020.03.22.002386; doi: https://doi.org/10.1101/2020.03.22.002386.
LKT Laboratories is a biochemical supply company focused on the synthesis, purification, and isolation of small molecules for research applications. All laboratory activities, including synthesis, natural product isolation, and full analytical characterization of our products are performed at our headquarters in St. Paul, MN. Call or email us if you have questions about the chemicals above or have a need for other chemicals not listed.